Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Condyloma. A new epidemic.

G E Moore, L W Norton, D M Meiselbaugh

    Archives of Surgery (Chicago, Ill. : 1960)
    |May 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Dinitrochlorobenzene immunotherapy effectively treated anal condyloma acuminatum resistant to traditional therapies. This immunotherapeutic approach shows promise as an additional treatment for this common condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The role of exercise prescription in chronic disease.

    British journal of sports medicine·2004
    Same author

    TBX22 mutations are a frequent cause of cleft palate.

    Journal of medical genetics·2004
    Same author

    The imprinted region on human chromosome 7q32 extends to the carboxypeptidase A gene cluster: an imprinted candidate for Silver-Russell syndrome.

    Journal of medical genetics·2003
    Same author

    Physical activity, hormone replacement therapy and plasma lipoprotein-lipid levels in postmenopausal women.

    International journal of sports medicine·2003
    Same author

    Characterisation of the growth regulating gene IMP3, a candidate for Silver-Russell syndrome.

    Journal of medical genetics·2002
    Same author

    Investigation of the GRB2, GRB7, and CSH1 genes as candidates for the Silver-Russell syndrome (SRS) on chromosome 17q.

    Journal of medical genetics·2002

    Area of Science:

    • Dermatology
    • Immunology
    • Oncology

    Background:

    • Condyloma acuminatum (anal warts) is a growing concern requiring multifaceted treatment strategies.
    • Conventional therapies include physical removal and topical chemotherapy, but some cases exhibit resistance.

    Purpose of the Study:

    • To evaluate the efficacy of dinitrochlorobenzene (DNCB) as an immunotherapeutic agent for recalcitrant anal condyloma acuminatum.
    • To compare DNCB treatment with 5-fluorouracil (5-FU) in patients with resistant lesions.

    Main Methods:

    • Twenty-three patients with anal condyloma acuminatum were skin tested with DNCB and 5-FU.
    • Patients were randomized to receive either DNCB or 5-FU treatment.
    • Lesion regression was assessed following treatment.

    Related Experiment Videos

    Main Results:

    • Excellent regression of lesions was observed in all but one patient treated with DNCB.
    • DNCB demonstrated superior efficacy compared to the control (5-FU) in this cohort.
    • The mechanism may involve stimulating a local cellular immune response.

    Conclusions:

    • Dinitrochlorobenzene immunotherapy is a highly effective treatment for anal condyloma acuminatum resistant to standard therapies.
    • Immunotherapeutic agents like DNCB represent a promising option for adjuvant therapy in managing this condition.